Iprindole is a tricyclic antidepressant (TCA) chemical compound primarily used in psychiatric research and pharmaceutical development as an antidepressant. It inhibits the reuptake of neurotransmitters such as serotonin and norepinephrine, helping to alleviate symptoms of depression in experimental models. Its unique pharmacological profile makes it suitable for studying the mechanisms of depression and neurotransmitter modulation in mood disorders. Iprindole is supplied as a high-purity reagent (≥98%) for laboratory and research applications only, not for human therapeutic use. Due to the availability of more advanced antidepressants with fewer side effects, its clinical use is now less common.